| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 82.80B | 85.53B | 93.94B | 101.56B | 85.25B | 64.36B |
| Gross Profit | 4.90B | 5.78B | 7.51B | 7.57B | 5.99B | 4.45B |
| EBITDA | 3.23B | 4.10B | 6.00B | 6.66B | 4.57B | 3.20B |
| Net Income | 1.10B | 1.80B | 3.48B | 4.34B | 2.71B | 1.77B |
Balance Sheet | ||||||
| Total Assets | 52.00B | 53.27B | 54.63B | 59.77B | 56.14B | 49.72B |
| Cash, Cash Equivalents and Short-Term Investments | 5.95B | 857.00M | 1.37B | 1.04B | 943.00M | 666.00M |
| Total Debt | 10.62B | 11.54B | 9.60B | 10.29B | 10.58B | 11.05B |
| Total Liabilities | 29.31B | 30.84B | 30.17B | 35.16B | 33.37B | 29.62B |
| Stockholders Equity | 22.43B | 22.17B | 24.13B | 24.28B | 22.48B | 20.00B |
Cash Flow | ||||||
| Free Cash Flow | 4.11B | 1.23B | 2.97B | 2.16B | 5.43B | -3.21B |
| Operating Cash Flow | 5.58B | 2.79B | 4.46B | 3.48B | 6.59B | -2.39B |
| Investing Cash Flow | -1.48B | -2.70B | -1.50B | -1.40B | -2.67B | 4.46B |
| Financing Cash Flow | -2.45B | -1.53B | -4.60B | -2.50B | -1.12B | -423.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| ― | $4.26B | 3.38 | 55.20% | 9.87% | 65.80% | 197.95% | |
| ― | $18.93B | 9.45 | 13.20% | 2.92% | -8.87% | 13.21% | |
| ― | $29.08B | 26.64 | 4.93% | 3.35% | -6.70% | -54.38% | |
| ― | $1.69B | 21.57 | 3.95% | 3.35% | 1.11% | 414.23% | |
| ― | $8.77B | 10.13 | ― | 3.38% | ― | ― | |
| ― | $17.93B | 22.85 | 4.31% | 3.89% | 1.99% | ― | |
| ― | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% |
On September 23, 2025, ADM announced a definitive agreement to form a North American Animal Feed Joint Venture with Alltech. This strategic move aims to transition ADM’s animal nutrition business into higher-margin specialty ingredients. The joint venture, expected to launch in the first quarter of 2026, will be majority-owned by Alltech and will combine the companies’ extensive experience and capabilities in animal nutrition. The venture will not materially impact ADM’s 2025 financial results but is part of ADM’s broader focus on optimizing its portfolio and streamlining operations to focus on higher-value growth.
The most recent analyst rating on (ADM) stock is a Buy with a $70.00 price target. To see the full list of analyst forecasts on Archer Daniels Midland stock, see the ADM Stock Forecast page.
Archer-Daniels-Midland Company (ADM) is a global leader in agricultural supply chain management and processing, providing essential food security and nutrition solutions worldwide. The company is recognized for its broad portfolio of ingredients and innovative bio-based solutions.
The recent earnings call of Archer-Daniels-Midland Company (ADM) painted a picture of a company advancing in cash flow generation and operational resilience, while also grappling with challenges in certain segments. The sentiment was a mix of optimism due to strategic investments and biofuel policy developments, tempered by difficulties in the Ag Services, Oilseeds, and Nutrition segments.